Bourne Lent Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-415,615
Closed -$41.3M 61
2019
Q3
$41.3M Sell
415,615
-7,050
-2% -$670K 19.79% 1
2019
Q2
$39.1M Hold
422,665
18.73% 1
2019
Q1
$39.9M Sell
422,665
-1,000
-0.2% -$87.5K 19.76% 1
2018
Q4
$27.2M Sell
423,665
-4,850
-1% -$358K 16.07% 1
2018
Q3
$38.3M Sell
428,515
-3,030
-0.7% -$268K 18.28% 1
2018
Q2
$34.3M Sell
431,545
-8,459
-2% -$702K 18.07% 1
2018
Q1
$39.3M Sell
440,004
-8,050
-2% -$773K 21.32% 1
2017
Q4
$46.8M Buy
448,054
+1,280
+0.3% +$144K 25.23% 1
2017
Q3
$65.1M Sell
446,774
-11,650
-3% -$1.59M 33.45% 1
2017
Q2
$59.5M Sell
458,424
-11,750
-2% -$1.44M 32.52% 1
2017
Q1
$58.5M Sell
470,174
-3,635
-0.8% -$435K 31.96% 1
2016
Q4
$54.8M Buy
473,809
+26,540
+6% +$2.96M 32.74% 1
2016
Q3
$46.8M Sell
447,269
-6,673
-1% -$722K 34.44% 1
2016
Q2
$44.8M Sell
453,942
-1,205
-0.3% -$125K 35.18% 1
2016
Q1
$45.6M Buy
455,147
+740
+0.2% +$76.2K 36.43% 1
2015
Q4
$54.4M Sell
454,407
-3,100
-0.7% -$359K 41.18% 1
2015
Q3
$49.5M Sell
457,507
-3,050
-0.7% -$378K 40.63% 1
2015
Q2
$53.3M Sell
460,557
-6,992
-1% -$799K 41.93% 1
2015
Q1
$53.9M Buy
+467,549
New +$55.9M 40.81% 1

Other funds holding CELG

Bourne Lent Asset Management's CELG Position: Q4 2019 in Review

Bourne Lent Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 415,615 shares — an estimated $41.3M sold.

Bourne Lent Asset Management first reported a position in CELG in Q1 2015 and held it in 19 quarters. The position peaked at $65.1M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bourne Lent Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bourne Lent Asset Management sold 415,615 Celgene Corp shares in Q4 2019, an estimated $41.3M.
  • Bourne Lent Asset Management first reported a position in Celgene Corp in Q1 2015 and held it in 19 quarters.
  • Bourne Lent Asset Management's Celgene Corp position peaked at $65.1M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bourne Lent Asset Management's 13F filing for Q4 2019, filed 24 Jan 2020.